Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis

MLA

Kai-Yen Lan, et al. “Fecal Microbiota Transplantation for Treatment of Refractory or Recurrent Clostridioides Difficile Infection in Taiwan: A Cost-Effectiveness Analysis.” Frontiers in Medicine, vol. 10, Oct. 2023. EBSCOhost, https://doi.org/10.3389/fmed.2023.1229148.

APA

Kai-Yen Lan, Puo-Hsien Le, Cheng-Tang Chiu, Chien-Chang Chen, Yuan-Ming Yeh, Hao-Tsai Cheng, Chia-Jung Kuo, Chyi-Liang Chen, Yi-Ching Chen, Pai-Jui Yeh, Cheng-Hsun Chiu, & Chee-Jen Chang. (2023). Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1229148

Chicago

Kai-Yen Lan, Puo-Hsien Le, Cheng-Tang Chiu, Chien-Chang Chen, Yuan-Ming Yeh, Hao-Tsai Cheng, Chia-Jung Kuo, et al. 2023. “Fecal Microbiota Transplantation for Treatment of Refractory or Recurrent Clostridioides Difficile Infection in Taiwan: A Cost-Effectiveness Analysis.” Frontiers in Medicine 10 (October). doi:10.3389/fmed.2023.1229148.